Comments
Loading...

Moderna

MRNANASDAQ
Logo brought to you by Benzinga Data
$82.44
1.41.73%
At Close: -
$82.50
0.060.07%
After Hours: 7:27 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$304.00
Lowest Price Target1
$80.00
Consensus Price Target1
$143.41

Moderna (NASDAQ:MRNA) Stock, Analyst Ratings, Price Targets, Forecasts

Moderna Inc has a consensus price target of $143.41 based on the ratings of 25 analysts. The high is $304 issued by Wolfe Research on November 9, 2021. The low is $80 issued by Deutsche Bank on August 6, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Deutsche Bank, and RBC Capital on August 15, 2024, August 6, 2024, and August 5, 2024, respectively. With an average price target of $86 between JP Morgan, Deutsche Bank, and RBC Capital, there's an implied 4.24% upside for Moderna Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
2
May
3
Jun
3
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Deutsche Bank
RBC Capital
Goldman Sachs
Barclays

1calculated from analyst ratings

Analyst Ratings for Moderna

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Moderna (MRNA) stock?

A

The latest price target for Moderna (NASDAQ:MRNA) was reported by JP Morgan on August 15, 2024. The analyst firm set a price target for $88.00 expecting MRNA to rise to within 12 months (a possible 6.67% upside). 36 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Moderna (MRNA)?

A

The latest analyst rating for Moderna (NASDAQ:MRNA) was provided by JP Morgan, and Moderna maintained their neutral rating.

Q

When was the last upgrade for Moderna (MRNA)?

A

The last upgrade for Moderna Inc happened on August 6, 2024 when Deutsche Bank raised their price target to $80. Deutsche Bank previously had a sell for Moderna Inc.

Q

When was the last downgrade for Moderna (MRNA)?

A

The last downgrade for Moderna Inc happened on August 5, 2024 when RBC Capital changed their price target from $125 to $90 for Moderna Inc.

Q

When is the next analyst rating going to be posted or updated for Moderna (MRNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

Q

Is the Analyst Rating Moderna (MRNA) correct?

A

While ratings are subjective and will change, the latest Moderna (MRNA) rating was a maintained with a price target of $96.00 to $88.00. The current price Moderna (MRNA) is trading at is $82.50, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch